Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (91-100 of 418) with videos related to

Pageof 42
Sort By:
Genes, Chromosomes & Cancer|November 11, 2011
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomasAntoine Italiano, Yun Shao Sung, Lei Zhang, et al.
Cancer Metastasis Reviews|September 18, 2025
Precision epigenetic therapies in oncologyArundhati Chaudhary, Kayleigh J A Orchard, Francesca Salani, et al.
Cancer Genetics and Cytogenetics|November 27, 2007
Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analysesMaxime Benchetritt, Véronique Hofman, Nicolas Vénissac, et al.
Cancer|September 22, 2007
Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experiencePierre-Yves Marcy, Nicolas Magné, Pierre Castadot, et al.
Journal of Hematology & Oncology|April 13, 2017
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomasAudrey Laroche, Vanessa Chaire, François Le Loarer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue SarcomasAudrey Laroche-Clary, Coralie Josensi, Marie-Alix Derieppe, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Radiology|April 10, 2019
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient OutcomeAmandine Crombé, Pierre-Jean Marcellin, Xavier Buy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Med (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.
Pageof 42

Showing results (91-100 of 418) with videos related to

Sort By:
Pageof 42
Genes, Chromosomes & Cancer|November 11, 2011
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomasAntoine Italiano, Yun Shao Sung, Lei Zhang, et al.
Cancer Metastasis Reviews|September 18, 2025
Precision epigenetic therapies in oncologyArundhati Chaudhary, Kayleigh J A Orchard, Francesca Salani, et al.
Cancer Genetics and Cytogenetics|November 27, 2007
Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analysesMaxime Benchetritt, Véronique Hofman, Nicolas Vénissac, et al.
Cancer|September 22, 2007
Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experiencePierre-Yves Marcy, Nicolas Magné, Pierre Castadot, et al.
Journal of Hematology & Oncology|April 13, 2017
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomasAudrey Laroche, Vanessa Chaire, François Le Loarer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue SarcomasAudrey Laroche-Clary, Coralie Josensi, Marie-Alix Derieppe, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Radiology|April 10, 2019
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient OutcomeAmandine Crombé, Pierre-Jean Marcellin, Xavier Buy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Med (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.
Pageof 42